Bank of New York Mellon Corp Sells 10,648 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Bank of New York Mellon Corp lessened its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 1.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 537,468 shares of the medical instruments supplier’s stock after selling 10,648 shares during the quarter. Bank of New York Mellon Corp’s holdings in Mettler-Toledo International were worth $657,688,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in MTD. Blue Trust Inc. lifted its position in Mettler-Toledo International by 242.9% during the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 17 shares during the period. Ashton Thomas Securities LLC acquired a new stake in shares of Mettler-Toledo International during the 3rd quarter worth approximately $37,000. Sound Income Strategies LLC raised its stake in shares of Mettler-Toledo International by 4,500.0% during the fourth quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock worth $56,000 after buying an additional 45 shares during the last quarter. Huntington National Bank lifted its holdings in Mettler-Toledo International by 20.0% in the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after buying an additional 9 shares during the period. Finally, Itau Unibanco Holding S.A. boosted its stake in Mettler-Toledo International by 80.0% in the third quarter. Itau Unibanco Holding S.A. now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after acquiring an additional 24 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on MTD. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their target price for the company from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Wolfe Research started coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating for the company. Robert W. Baird increased their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Stifel Nicolaus decreased their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Finally, Evercore ISI increased their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research report on Monday, February 10th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $1,368.00.

Insider Buying and Selling

In related news, insider Gerry Keller sold 140 shares of the company’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now directly owns 6 shares of the company’s stock, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,310.50 on Wednesday. Mettler-Toledo International Inc. has a one year low of $1,142.91 and a one year high of $1,546.93. The firm has a market cap of $27.42 billion, a P/E ratio of 32.33, a P/E/G ratio of 3.30 and a beta of 1.13. The stock’s 50-day moving average is $1,287.86 and its 200-day moving average is $1,331.78.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. Equities analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.